Bioequivalence Study of Fixed Dose Combinations of Saxagliptin/Metformin Extended Release (XR) Relative to Co-administration of the Individual Components in Healthy Subjects in the Fasted and Fed States
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008150/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To demonstrate the bioequivalence of saxagliptin and metformin in a saxagliptin,
5-mg/metformin extended-release (XR), 500-mg, fixed-dose combination (FDC) tablet with
saxagliptin, 5-mg and metformin, 500-mg XR tablets administered together in both the fasted
and fed states. In addition, to demonstrate the bioequivalence of saxagliptin and metformin
in a saxagliptin, 5-mg/metformin XR, 1000-mg, FDC tablet with saxagliptin, 5-mg and
metformin, 1000-mg XR tablets administered together in both the fasted and fed states.
提供机构：
Vivli
创建时间：
2022-06-29
